Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Milestone Pharmaceuticals Inc. (MIST)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Cash flows used in operating activities          
Net loss  -16.0-15.0-14.6-16.6-14.0-16.9-14.20.8
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Depreciation of property and equipment  0.00.00.00.00.00.00.00.0
    Amortization of debt costs  0.1       
    Accretion of investment discount  0.0-0.1      
    Non-cash interest expense related to debt  0.8       
    Share-based compensation expense  2.52.32.42.42.12.02.01.9
    Changes in operating assets and liabilities:          
        Other receivables  -0.40.2-0.20.0-0.10.00.20.0
        Research and development tax credits receivable  -0.1-0.10.3-0.1-0.1-0.10.6-0.1
        Prepaid expenses  0.00.6-1.60.60.21.71.5-1.2
        Operating lease assets and liabilities  0.00.00.10.00.0 0.00.0
        Accounts payable and accrued liabilities  1.6-0.91.9-0.3-2.11.00.5-0.5
            Net cash used in operating activities  -10.6-13.9-11.6-14.1-13.9-12.4-9.41.0
   
Cash provided by (used in) investing activities          
Acquisition of property and equipment  0.00.0-0.1-0.1    
Acquisition of short-term investments  -55.0-15.0-39.9-15.0-8.0 -15.0 
Redemption of short-term investments  27.045.023.0  15.038.020.0
    Net cash provided by (used in) investing activities  -28.030.0-17.1-15.1-8.015.023.020.0
   
Cash provided by financing activities          
Proceeds from exercise of options  -0.10.30.00.10.00.10.0 
Proceeds from issuance of senior secured convertible debt   50.0      
Pre-funded warrant issuance costs  0.0       
Proceeds from employee stock purchase plan  0.00.1 0.10.0   
Payment of debt issuance costs  -2.8       
    Cash provided by financing activities  -2.850.32.70.10.00.10.04.9
    Net increase (decrease) in cash and cash equivalents  -41.466.3 -29.0-21.9   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy